Literature DB >> 26195764

Norbin ablation results in defective adult hippocampal neurogenesis and depressive-like behavior in mice.

Hong Wang1, Jennifer Warner-Schmidt2, Santiago Varela2, Grigori Enikolopov3, Paul Greengard1, Marc Flajolet1.   

Abstract

Adult neurogenesis in the hippocampus subgranular zone is associated with the etiology and treatment efficiency of depression. Factors that affect adult hippocampal neurogenesis have been shown to contribute to the neuropathology of depression. Glutamate, the major excitatory neurotransmitter, plays a critical role in different aspects of neurogenesis. Of the eight metabotropic glutamate receptors (mGluRs), mGluR5 is the most highly expressed in neural stem cells. We previously identified Norbin as a positive regulator of mGluR5 and showed that its expression promotes neurite outgrowth. In this study, we investigated the role of Norbin in adult neurogenesis and depressive-like behaviors using Norbin-deficient mice. We found that Norbin deletion significantly reduced hippocampal neurogenesis; specifically, the loss of Norbin impaired the proliferation and maturation of newborn neurons without affecting cell-fate specification of neural stem cells/neural progenitor cells (NSCs/NPCs). Norbin is highly expressed in the granular neurons in the dentate gyrus of the hippocampus, but it is undetectable in NSCs/NPCs or immature neurons, suggesting that the effect of Norbin on neurogenesis is likely caused by a nonautonomous niche effect. In support of this hypothesis, we found that the expression of a cell-cell contact gene, Desmoplakin, is greatly reduced in Norbin-deletion mice. Moreover, Norbin-KO mice show an increased immobility in the forced-swim test and the tail-suspension test and reduced sucrose preference compared with wild-type controls. Taken together, these results show that Norbin is a regulator of adult hippocampal neurogenesis and that its deletion causes depressive-like behaviors.

Entities:  

Keywords:  Norbin; glutamate; mGluR5; major depressive disorder; neurogenesis

Mesh:

Substances:

Year:  2015        PMID: 26195764      PMCID: PMC4534263          DOI: 10.1073/pnas.1510291112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  The mGlu5 metabotropic glutamate receptor is expressed in zones of active neurogenesis of the embryonic and postnatal brain.

Authors:  V D Di Giorgi Gerevini; A Caruso; I Cappuccio; L Ricci Vitiani; S Romeo; C Della Rocca; R Gradini; D Melchiorri; F Nicoletti
Journal:  Brain Res Dev Brain Res       Date:  2004-05-19

Review 2.  Forced swimming test in mice: a review of antidepressant activity.

Authors:  Benoit Petit-Demouliere; Franck Chenu; Michel Bourin
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

3.  Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and interindividual differences.

Authors:  C K Nielsen; J Arnt; C Sánchez
Journal:  Behav Brain Res       Date:  2000-01       Impact factor: 3.332

4.  Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine.

Authors:  B Czéh; T Michaelis; T Watanabe; J Frahm; G de Biurrun; M van Kampen; A Bartolomucci; E Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

5.  Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.

Authors:  J E Malberg; A J Eisch; E J Nestler; R S Duman
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

Review 6.  The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.

Authors:  John F Cryan; Cedric Mombereau; Annick Vassout
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

7.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

Review 8.  The current state of the neurogenic theory of depression and anxiety.

Authors:  Bradley R Miller; René Hen
Journal:  Curr Opin Neurobiol       Date:  2014-09-18       Impact factor: 6.627

9.  Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.

Authors:  Luca Santarelli; Michael Saxe; Cornelius Gross; Alexandre Surget; Fortunato Battaglia; Stephanie Dulawa; Noelia Weisstaub; James Lee; Ronald Duman; Ottavio Arancio; Catherine Belzung; René Hen
Journal:  Science       Date:  2003-08-08       Impact factor: 47.728

10.  Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells.

Authors:  V Di Giorgi-Gerevini; D Melchiorri; G Battaglia; L Ricci-Vitiani; C Ciceroni; C L Busceti; F Biagioni; L Iacovelli; A M Canudas; E Parati; R De Maria; F Nicoletti
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

View more
  24 in total

1.  The GPCR adaptor protein norbin suppresses the neutrophil-mediated immunity of mice to pneumococcal infection.

Authors:  Chiara Pantarelli; Dingxin Pan; Stephen Chetwynd; Anne-Katrien Stark; Kirsti Hornigold; Polly Machin; Laraine Crossland; Simon J Cleary; Martin J Baker; Elizabeth Hampson; Anna Mandel; Anne Segonds-Pichon; Rachael Walker; Cornelis van 't Veer; Yanira Riffo-Vasquez; Klaus Okkenhaug; Simon Pitchford; Heidi C E Welch
Journal:  Blood Adv       Date:  2021-08-24

Review 2.  Chronic peripheral inflammation, hippocampal neurogenesis, and behavior.

Authors:  Vera Chesnokova; Robert N Pechnick; Kolja Wawrowsky
Journal:  Brain Behav Immun       Date:  2016-01-21       Impact factor: 7.217

Review 3.  Metabotropic glutamate receptor trafficking.

Authors:  Young Ho Suh; Kai Chang; Katherine W Roche
Journal:  Mol Cell Neurosci       Date:  2018-03-29       Impact factor: 4.314

Review 4.  Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications.

Authors:  Alexandria N Tartt; Madeline B Mariani; Rene Hen; J John Mann; Maura Boldrini
Journal:  Mol Psychiatry       Date:  2022-03-30       Impact factor: 13.437

5.  The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids.

Authors:  Weiping Xiao; Jiabin Su; Xinjie Gao; Heng Yang; Ruiyuan Weng; Wei Ni; Yuxiang Gu
Journal:  Microbiome       Date:  2022-04-17       Impact factor: 14.650

Review 6.  Exosomes as Novel Regulators of Adult Neurogenic Niches.

Authors:  Luis Federico Bátiz; Maite A Castro; Patricia V Burgos; Zahady D Velásquez; Rosa I Muñoz; Carlos A Lafourcade; Paulina Troncoso-Escudero; Ursula Wyneken
Journal:  Front Cell Neurosci       Date:  2016-01-19       Impact factor: 5.505

Review 7.  Actions of Brain-Derived Neurotrophic Factor and Glucocorticoid Stress in Neurogenesis.

Authors:  Tadahiro Numakawa; Haruki Odaka; Naoki Adachi
Journal:  Int J Mol Sci       Date:  2017-11-02       Impact factor: 5.923

Review 8.  Resveratrol: A Potential Hippocampal Plasticity Enhancer.

Authors:  Gisele Pereira Dias; Graham Cocks; Mário Cesar do Nascimento Bevilaqua; Antonio Egidio Nardi; Sandrine Thuret
Journal:  Oxid Med Cell Longev       Date:  2016-05-25       Impact factor: 6.543

9.  Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depression.

Authors:  Ren-Hong Du; Fang-Fang Wu; Ming Lu; Xiao-Dong Shu; Jian-Hua Ding; Guangyu Wu; Gang Hu
Journal:  Redox Biol       Date:  2016-08-18       Impact factor: 11.799

10.  Norbin Stimulates the Catalytic Activity and Plasma Membrane Localization of the Guanine-Nucleotide Exchange Factor P-Rex1.

Authors:  Dingxin Pan; Mark A Barber; Kirsti Hornigold; Martin J Baker; Judit M Toth; David Oxley; Heidi C E Welch
Journal:  J Biol Chem       Date:  2016-01-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.